Related Experiment Video

Updated: Jul 17, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

[Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor]

Laurence Denat1, Lionel Larue

  • 1Developmental Genetics of Melanocytes, UMR146 CNRS, Institut Curie, Bât. 110, 91405, Orsay Cedex. laurence.denat@curie.net

Bulletin Du Cancer
|January 24, 2007
PubMed

Insights

The microphthalmia-associated transcription factor (Mitf) is crucial for melanocyte development and function. While vital for melanoma, it may not be the sole diagnostic marker for this cancer.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Context:

  • The microphthalmia-associated transcription factor (Mitf) is a key regulator in the melanocyte lineage.
  • Mitf controls critical cellular processes including differentiation, morphology, proliferation, and survival.
  • Its role extends from melanoblasts to mature melanocytes and melanoma cells.

Purpose:

  • To elucidate the multifaceted roles of Mitf in the melanocyte lineage.
  • To investigate Mitf's involvement in melanogenesis, cell cycle regulation, and cell behavior.
  • To assess the potential of Mitf as a diagnostic and prognostic marker for cutaneous melanoma.

Summary:

  • Mitf protein is central to signaling pathways governing melanocyte development and function.
  • It induces key melanogenesis enzymes (tyrosinase, Tyrp1, Dct) and regulates melanocyte morphology and migration.
  • Mitf exhibits a dual role in cell proliferation, typically inhibiting the cell cycle but capable of inducing it in specific contexts.
  • Adequate Mitf levels are essential for melanoblast survival.

Impact:

  • Mitf is proposed as a diagnostic/prognostic marker for cutaneous melanoma.
  • This research prompts a critical evaluation of whether Mitf can serve as the unique marker for melanoma diagnosis.
  • Understanding Mitf's complex roles is crucial for developing targeted melanoma therapies.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...